Comment on: Five-years drug survival of mycophenolate mofetil therapy in patients with systemic lupus erythematosus: comparison between renal and non-renal…
The European Lupus Society (SLEuro) was founded on 30 th September 2016 in Venice (Italy) few days before the 10th European Lupus Meeting 2016.
Ongoing developments in compliance and transparency as well as the need of a solid infrastructure for European Lupus meetings and community, called for the foundation of a new association: SLEuro.
The Society pursues the following goals: building up a community of clinicians and researchers interested in SLE with special focus to engage younger physicians in the field; promoting and coordinating the organisation of research and educational meetings on SLE and related syndromes; promoting equal access to best standard of care for SLE patients across Europe and facilitating research projects and clinical trials in SLE.
Comment on: “Efficacy and safety of voclosporin versus placebo for lupus nephritis (AURORA 1): a double-blind, randomised, multicentre, placebo-controlled, phase…
Comment on: “Molecular pathways in patients with systemic lupus erythematosus revealed by gene-centred DNA sequencing” (Ann Rheum Dis. 2021; 80(1):109-117….
Follow us on